Skip to content
2000
Volume 22, Issue 7
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

It is well known that cancer is the second leading cause of death worldwide. Due to this fact, new results for the treatment of cancer are constantly being introduced and verified. Imidazolidine derivatives regulate cell cycle progression and DNA stability. Structurally, a heterocyclic nucleus favors a direct DNA interaction and therefore, control of the DNA replication process. This review aims not only to discuss the role of imidazolidines in cancer therapy but also explore the functionality of such agents in the future aspects of cancer prognosis and treatment. Convincing data from 1996 to 2021 has presented imidazolidine derivatives as a relevant therapeutic tool to modulate cancer progression and malignancy. Here we highlight these aspects in a variety of cell lines, cancer types, involving in vitro and in vivo techniques.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520621666210727113639
2022-04-01
2025-03-15
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520621666210727113639
Loading

  • Article Type:
    Review Article
Keyword(s): anticancer; Apoptosis; cancer; cell cycle; DNA; imidazolidine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test